Markku H Vaarala

Markku H Vaarala

UNVERIFIED PROFILE

Are you Markku H Vaarala?   Register this Author

Register author
Markku H Vaarala

Markku H Vaarala

Publications by authors named "Markku H Vaarala"

Are you Markku H Vaarala?   Register this Author

35Publications

587Reads

11Profile Views

Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer.

BJU Int 2019 May 18. Epub 2019 May 18.

Departments of Urology, Pathology and Radiology, and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14812DOI Listing
May 2019

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

N Engl J Med 2018 May 18;378(19):1767-1777. Epub 2018 Mar 18.

From University College London (UCL) and UCL Hospitals NHS Foundation Trust (V.K., C.A., F.G., A.F., S.M., S.P., M.E., C.M.M.), London North West Healthcare NHS Trust (G.H.), Whittington Health NHS Trust (M.G.), Royal Free London NHS Foundation Trust (P.B.S.), and UCL Surgical and Interventional Trials Unit (N.R.W., C.B.-G.), London, Hampshire Hospitals NHS Foundation Trust, Basingstoke (R.G.H.), Princess Alexandra Hospital NHS Trust, Harlow (J.V.), and the Institute of Applied Health Research and the NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham (J.D., Y.T.) - all in the United Kingdom; Helsinki University and Helsinki University Hospital, Helsinki (A.S.R.), and Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu (M.H.V.) - all in Finland; Centro de Urología, Buenos Aires (M.B.); Sapienza University, Rome (V.P.), and IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan (A.B.) - all in Italy; Mayo Clinic, Rochester, MN (L.A.M.); Martini Klinik, Hamburg (L.B.), University Hospital Essen, Essen (B.A.H.), and University Hospital Heidelberg, Heidelberg (B.A.H.) - all in Germany; Erasmus University Medical Center, Rotterdam (M.J.R.), and Radboud University Medical Center, Nijmegen (W.V.) - both in the Netherlands; University of Chicago, Chicago (S.E.); Université de Lille and Centre Hospitalier Universitaire Lille, Lille (A.V.), Université de Bordeaux and Bordeaux Pellegrin University Hospital, Bordeaux (G.R.), and Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud (A.R.), and Hospices Civils de Lyon of the Hôpital Edouard Herriot (S.C.), Lyon - all in France; Jewish General Hospital, Montreal (F.B.), and Sunnybrook Health Sciences Centre, Toronto (L.K.) - both in Canada; Ghent University Hospital, Ghent, Belgium (G.M.V.); University Hospital Bern, Bern, Switzerland (S.B.); Weill Cornell Medicine, New York-Presbyterian Hospital (J.C.H., D.M.), and New York University Langone Medical Center (S.S.T.), New York; National Institutes of Health, Bethesda, MD (P.P.); and the University of Southern California Institute of Urology, Keck School of Medicine, Los Angeles (I.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1801993DOI Listing
May 2018

Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology.

Scand J Urol 2018 Apr 1;52(2):111-115. Epub 2018 Jan 1.

a Departments of Diagnostic Radiology, Pathology and Surgery , Medical Research Center Oulu, Oulu University Hospital and University of Oulu , Oulu , Finland.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/21681805.2017.1
Publisher Site
http://dx.doi.org/10.1080/21681805.2017.1414872DOI Listing
April 2018

Urinary Sample Collection Methods in Ileal Conduit Urinary Diversion Patients: A Randomized Control Trial.

Authors:
Markku H Vaarala

J Wound Ostomy Continence Nurs 2018 Jan/Feb;45(1):59-62

Markku H. Vaarala, MD, PhD, Division of Operative Care and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WON.0000000000000397DOI Listing
April 2018

External beam radiation for the treatment of castration-resistant prostate cancer following primary hormonal therapy with androgen ablation: Analysis and outcome of 21 patients.

Mol Clin Oncol 2017 Mar 6;6(3):428-432. Epub 2017 Feb 6.

Division of Operative Care and Medical Research Center Oulu, Oulu University Hospital, 90220 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2017.1156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403359PMC
March 2017

Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent I seed brachytherapy for prostate cancer.

Mol Clin Oncol 2016 Nov 13;5(5):647-650. Epub 2016 Sep 13.

Department of Operative Care, Division of Urology, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, 90220 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2016.1014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103891PMC
November 2016

Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up.

Oncol Lett 2016 Aug 13;12(2):1149-1153. Epub 2016 Jun 13.

Department of Surgery, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, 90029 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950901PMC
August 2016

Treatment of renal angiomyolipoma: pooled analysis of individual patient data.

BMC Urol 2015 Dec 28;15:123. Epub 2015 Dec 28.

Department of Surgery and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, PO Box 21, 90029 OYS, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12894-015-0118-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693425PMC
December 2015

Tumor infiltrating CD8 T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma.

Oncoimmunology 2015 Jun 22;4(6):e1002726. Epub 2015 May 22.

Department of Pathology; Lapland Central Hospital ; Rovaniemi, Finland ; Department of Medicine; Division of Hematology & Oncology; University of Alabama at Birmingham ; Birmingham, AL, USA ; Comprehensive Cancer Center; University of Alabama at Birmingham ; Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2014.1002726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485740PMC
June 2015

DuraSeal as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer.

Radiother Oncol 2014 Aug 4;112(2):233-6. Epub 2014 Sep 4.

Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2014.08.012DOI Listing
August 2014

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.

Nat Genet 2014 Feb 5;46(2):126-35. Epub 2014 Jan 5.

1] Biocenter Oulu, University of Oulu, Oulu, Finland. [2] Department of Medical Biochemistry and Molecular Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2862DOI Listing
February 2014

Sacral nerve stimulation lead implantation using the O-arm.

BMC Urol 2013 Oct 16;13:48. Epub 2013 Oct 16.

Division of Operative Care and Medical Research Center, Oulu University Hospital, P,O, Box 20, Oulu, FIN 90029 OYS, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2490-13-48DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852713PMC
October 2013

Identification of androgen-regulated genes in human prostate.

Mol Med Rep 2012 Sep 19;6(3):466-72. Epub 2012 Jun 19.

Department of Surgery, Oulu University Hospital, and Department of Pathology, University of Oulu, FIN-90029 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2012.956DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493087PMC
September 2012

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma.

J Exp Clin Cancer Res 2011 Sep 19;30:84. Epub 2011 Sep 19.

Department of Surgery, Oulu University Hospital, PO Box 21, 90029 OYS, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-30-84DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182949PMC
September 2011

HuR expression is a marker of poor prognosis in renal cell carcinoma.

Tumour Biol 2011 Jun 16;32(3):481-7. Epub 2010 Dec 16.

Department of Surgery, Oulu University Hospital, PO Box 21, 90029 OYS, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-010-0141-6DOI Listing
June 2011

8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.

Int J Clin Exp Pathol 2011 Mar 2;4(3):267-75. Epub 2011 Mar 2.

Department of Clinical Pathology and Forensic Medicine, Institute of Clinical Medicine, School of Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071659PMC
March 2011

Sacral neuromodulation in urological indications: the Finnish experience.

Scand J Urol Nephrol 2011 Feb 21;45(1):46-51. Epub 2010 Oct 21.

Department of Surgery, Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365599.2010.523013DOI Listing
February 2011

Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.

Oncol Rep 2011 Jan;25(1):129-33

Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
January 2011

Is the incidence of urinary bladder endometriosis increasing? Figures from Finland.

Gynecol Obstet Invest 2010 25;70(1):55-9. Epub 2010 Feb 25.

Department of Surgery, Division of Urology, Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000288161DOI Listing
November 2010

CIP2A expression is increased in prostate cancer.

J Exp Clin Cancer Res 2010 Oct 21;29:136. Epub 2010 Oct 21.

Department of Surgery, Oulu University Hospital, PO Box 21, 90029 OYS, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-29-136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984408PMC
October 2010

Evaluation of neuroendocrine markers in renal cell carcinoma.

Diagn Pathol 2010 May 12;5:28. Epub 2010 May 12.

Department of Surgery, PO Box 21, Oulu University Hospital, FIN-90029 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1746-1596-5-28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876076PMC
May 2010

Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma.

J Exp Clin Cancer Res 2010 Jan 14;29. Epub 2010 Jan 14.

Department of Surgery, PO Box 21, Oulu University Hospital, FIN-90029 Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-29-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837630PMC
January 2010

Myosin VI is a modulator of androgen-dependent gene expression.

Oncol Rep 2009 Nov;22(5):991-5

Department of Pathology, University of Oulu, Oulu University Hospital, Oulu, 90029 OYS, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or_00000526DOI Listing
November 2009

Retrospective analysis of long-term outcomes of 64 patients treated by endopyelotomy in two low-volume hospitals: good and durable results.

J Endourol 2008 Aug;22(8):1659-64

Department of Surgery, Division of Urology, Oulu University Hospital, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2008.0117DOI Listing
August 2008

The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.

Int J Cancer 2008 Jun;122(11):2511-6

Department of Pathology, University of Oulu, Oulu, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.23425DOI Listing
June 2008

Characterization of androgen-regulated expression of CYP3A5 in human prostate.

Carcinogenesis 2007 May 20;28(5):916-21. Epub 2006 Nov 20.

Department of Pathology, University of Oulu and University Hospital of Oulu, FIN-90014 Oulu, Finland.

View Article

Download full-text PDF

Source
http://carcin.oxfordjournals.org/content/28/5/916.full.pdf
Web Search
http://www.carcin.oxfordjournals.org/cgi/doi/10.1093/carcin/
Publisher Site
http://dx.doi.org/10.1093/carcin/bgl222DOI Listing
May 2007